Compass therapeutics to be added to the russell 2000® and russell 3000® indexes

Boston, june 22, 2023 (globe newswire) -- compass therapeutics, inc. (nasdaq: cmpx), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, today announced that it will be added to the russell 2000 ® and russell 3000 ® indexes as part of the russell indexes annual reconstitution, effective after the us market opens on june 26, 2023.
CMPX Ratings Summary
CMPX Quant Ranking